MarkNathanielFluchelMD
Pediatric Hematology & Oncology • Salt Lake City, UTAssistant Professor, Pediatrics, University of Utah School of Medicine
Are you Dr. Fluchel?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Connect with colleagues in the same hospital or clinic
You already have 48 invites waiting! - Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
100 Mario Capecchi Dr
Salt Lake City, UT 84113Phone+1 801-662-4700Fax+1 801-662-4705- Is this information wrong?
Summary
- Dr. Mark Fluchel, MD is a pediatric hematologist/oncologist in Salt Lake City, Utah. He is currently licensed to practice medicine in Utah, Montana, and Pennsylvania. He is affiliated with University of Utah Health and Primary Children's Hospital.
Education & Training
Children's Hospital of PhiladelphiaFellowship, Pediatric Hematology/Oncology, 2004 - 2007
University of WashingtonResidency, Pediatrics, 2000 - 2003
Vanderbilt University School of MedicineClass of 2000
Certifications & Licensure
WA State Medical License 2003 - 2026
UT State Medical License 2007 - 2024
MT State Medical License 2016 - 2020
PA State Medical License 2004 - 2008- American Board of Pediatrics Pediatric Hematology-Oncology
Clinical Trials
- Preventative Trial of DFMO in Patients With High Risk Neuroblastoma in Remission Start of enrollment: 2012 Jun 01
- Molecular-Guided Therapy for Relapsed and Refractory Childhood Cancer Start of enrollment: 2013 Feb 01
- Molecular-Guided Therapy for Childhood Cancer Start of enrollment: 2014 Jul 08
- Join now to see all
Publications & Presentations
PubMed
- Vaccination practices of pediatric oncologists from eight states.Karely M van Thiel Berghuijs, Heydon K Kaddas, Echo L Warner, Douglas B Fair, Mark Fluchel, Elizabeth D Knackstedt, Anupam Verma, Deanna Kepka, Adam L Green, Andrew B ...> ;BMC Health Services Research. 2023 Nov 7
- 2 citationsChildren's Oncology Group's 2023 blueprint for research: Non-Hodgkin lymphoma.Nader Kim El-Mallawany, Sarah Alexander, Mark Fluchel, Robert J Hayashi, Eric J Lowe, Lisa Giulino-Roth, Birte Wistinghausen, Michelle Hermiston, Carl E Allen> ;Pediatric Blood & Cancer. 2023 Sep 1
- A phase II trial of nifurtimox combined with topotecan and cyclophosphamide for refractory or relapsed neuroblastoma and medulloblastoma.Don Eslin, Peter E Zage, Genevieve Bergendahl, Elizabeth Lewis, William Roberts, Jacqueline Kraveka, Deanna Mitchell, Michael S Isakoff, Jawhar Rawwas, Randal K Wada, ...> ;International Journal of Cancer. 2023 Sep 1
- Join now to see all
Hospital Affiliations
Primary Children's HospitalSalt Lake City, Utah
University of Utah HealthSalt Lake City, Utah
